AMIX - CIK 0001617867
The table below shows Autonomix Medical, Inc.'s cash flow statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating cash flow | -$12.28M | -$8.26M | -$6.60M | -$1.85M |
| Capital expenditure | $10.00K | $14.00K | $19.00K | $0.00 |
| Investing cash flow | -$10.00K | -$14.00K | -$19.00K | $0.00 |
| Dividends paid | - | - | - | - |
| Stock buybacks | - | - | - | - |
| Financing cash flow | $10.16M | $8.80M |
Autonomix Medical, Inc. reported operating cash flow of -$12.28M for fiscal year 2026. That is down 48.7% from -$8.26M in fiscal 2025. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $14.41M |
| $675.00K |